Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Fe Pharmaceuticals logo — Treating diseases where iron is at the core

Fe Pharmaceuticals

Treating diseases where iron is at the core

Founded 2012 United States Redwood City, United States 5 employees Pharmaceutical

General Information

Company Name Fe Pharmaceuticals
Founded Year 2012
Location United States Redwood City, United States +2
Employees 5
Industries Pharmaceutical
Social

Get notified when Fe Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Fe Pharmaceuticals

Fe Pharmaceuticals is a pharmaceutical startup founded in 2012 with the slogan "Treating diseases where iron is at the core." The company is developing DIBI, a non-toxic, iron-binding copolymer, positioned as a potent (uM MIC), broad-spectrum, antimicrobial agent effective against bacterial and fungal infections, including drug-resistant organisms. DIBI has also shown promise in treating sepsis, inflammatory disorders, and cancer. With 22 published studies characterizing its potential, this water-soluble polymer is deemed ideal for various administration routes. In animal studies, it has demonstrated non-toxic qualities. Additionally, its unique mode of action makes it resistant to microbial resistance, and it also inhibits the development of resistance to co-administered antibiotics. Fe Pharmaceuticals is an intriguing player in the pharmaceutical industry, pioneering a novel approach to combatting infectious diseases.

Taxonomy: Infectious Disease Treatment, Antimicrobial Agents, Drug Resistance, Cancer Treatment, Sepsis Therapy, Biomedical Research, Iron Metabolism Regulation, Biopolymer Development, Medical Innovation, Drug Development, Startup Incubator

No funding data available for Fe Pharmaceuticals yet.

Get notified when Fe Pharmaceuticals raises funding

Fe Pharmaceuticals Alternatives & Competitors

Fe Pharmaceuticals vs
Microbion Corporation
Microbion Corporation United States

Developing a disruptive new class of therapeutic drugs for the treatment of rare, chronic, and serio...

Series Unknown
16 employees
Biotechnology, Health Care
Fe Pharmaceuticals vs
TOLREMO therapeutics
TOLREMO therapeutics Switzerland

Stopping non-genetic cancer drug resistance as it emerges

Series A
14 employees
Biotechnology, Pharmaceutical
Fe Pharmaceuticals vs
Tetraphase Pharmaceuticals
Tetraphase Pharmaceuticals United States

Fighting against antimicrobial resistance is at the core of our technology and our people.

Grant
14 employees
Biopharma, Biotechnology

FAQ About Fe Pharmaceuticals

Treating diseases where iron is at the core
Fe Pharmaceuticals was founded in 2012.
Fe Pharmaceuticals is headquartered in Redwood City, United States.
Fe Pharmaceuticals operates in the following industries: Pharmaceutical.
Fe Pharmaceuticals has approximately 5 employees.
Top alternatives and competitors to Fe Pharmaceuticals include Microbion Corporation, TOLREMO therapeutics, Tetraphase Pharmaceuticals, BioVersys AG, Madam Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Fe Pharmaceuticals and Microbion Corporation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Fe Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy